All Episodes

11.OB:sec.1-18of18-APGAR & neonatal resuscitation

11.sec.1-17of18-Obstetric Bleeding

11.OB:sec.1-16of18-Disorders of the Placenta

11.OB:sec.1-15of18-OB hypertensive d/o:pathophysiology

11.OB:sec.1-14-18-Nonobstetrics Surgery during pregnancy

11.OB:sec.1-13of18-c/s: General Anesthesia

11.OB:sec.1-12of18-Uterotonic Drugs

11.OB:sec.1-11of18-Prematurity & tocolysis

11.OB:sec.1-10of18-Three Tier system for eval of FHR

11.OB:sec.1-9of18-Fetal Heart Rate

11.OB:sec.1-8of18-Total Spinal

11.OB-sec.1-7of18-Local Anesthetics

11.OB:sec.1-6of18-Labor Pain

11OB:sec.1-5of-18-Stages of Labor

11.OBstetrics:sec.4of18-The Uterus

11.Obstetrics:sec.1-3of18-Physiologic Changes during pregnan

11.Obstetrics:sec.1-2of18-Physiologic Changes during pregnan

11.Obstetrics:sec.1-of18-Physiologic changes during pregnanc

8.Neuraxial:sec.1-16of16-Cauda Equina & TNS

8.Neuraxial:sec.1-15of16-Antiplatelet & anticoagulants

8.Neuraxial:sec.1-14of16-Postdural puncture headache & menin

8.Neuraxial:sec.1-13of16-Neuraxial opioid side effects

8.Neuraxial:sec.1-12of16-Neuraxial Opioids

8.Neuraxial:11of16-Caudal Anesthesia

8.Neuraxial:sec.1-10of16-spinal & epidural needles

8.Neuraxial:sec.1-9of10-Baricity

8.Neuraxial:sec.1-8of16-Contraindications to Neuraxial Anest

8.Neuraxial:sec.1-7of16-systemic effects of Neuraxial Anesth

8.Neuraxial:sec.1-6of16-site of action, spread, differentia

8.Neuraxial:sec.1-5of16-Dermatomes

8.Neuraxial:sec.1-4of16-Sacral Anatomy

8.Neuraxial:sec.1-3of15-The epidural & SAB spaces

8.Neuraxial:sec1-2of16-Ligaments of the spinal column

8.Neuraxial:sec.1-1of16-Anatomy of the Back Bone

7.Neuro:sec3-15of15-Musculoskeletal dse part 2

7.Neuro:sec.3-14of15-selected Musculoskeletal dse

7.Neuro:sec.3-13of15-SLE

7.Neuro:sec.3-12of15-RA:Pathophys

7.Neuro:sec.3-11of15-Rheumatoid Arthritis

7.Neuro:sec.3-10of15-Scoliosis

7.Neuro:sec.3-9of15-Muscular Dystrophy

7.Neuro:sec.1-8of15-MH:treatment

7.Neuro:MH: Clinical Presentation

7.Neuro:sec.3-6of15-Malignant Hyperthermia

7.Neuro:sec.3-5of15-Familial Periodic Paralysis

7.Neuro:sec.3-4of15-Guillain-Barre Syndrome

7.Neuro:sec.3-3of15-Eaton-Lambert Syndrome (Myasthenic Syndr

7.Neuro:sec.3-2of15-MG:NMB & postop concerns

7.Neuro:sec.3-1of15-Myasthenia Gravis

7.Neuro:Sec.2-8of8-Amyotrophic Lateral Sclerosis

7.Neuro:sec.2-7of8-Autonomic Hyperreflexia

7.Neuro:sec.2-6of8-Acute Spinal cord injury: Neurogenic Shoc

7.Neuro:sec.2-5of8-Motor pathways: Corticospinal Tract

7.Neuro:sec.2-4of8-Sensory Pathways:Anyerolateral system-spi

7.Neuro:sec.2-3of8-Sensory pathway: Dorsal Column- Medial Le

7.Neuro:Sec.2-2of8-Anatomy Overview

7.Neuro:sec.2-1of8-Spinal Cord blood flow

7.Neuro:sec.1-16of16-Ischemic optic neuropathy & CRAO

7.Neuro:sec.1-15of16-Parkinson’s Disease

7.Neuro:sec.1-14of16-Alzheimer’s Disease

Neuro:sec.1-13of16-Anticonvulsant

7.Neuro:sec.1-12of16-seizure disorder

7.Neuro:sec.1-11of16-Traumatic Brain Injury

7.Neuro:Sec.1-10of16-Cerebral Aneurysm

7.Neuro:sec.1-9of16-ischemic Stroke

7.Neuro:sec.1-8of16-Cerebrovascular Anatomy

7.Neuro:sec.1-7of16-Intracranial HTN:treatment

7.Neuro:sec.1-6of16-ICP

7.Neuro:sec.1-5of16-CBF

7.Neuro:sec.1-4of16-CSF Dynamics and the BBB

7.Neuro:sec.1-3of16-Cranial Nerves

7.Neuro:sec.1-2of16-Gross structures of the Brain

7.Neuro-sec.1-1of16-CNS

6.Equipments:Sec.6:5of5-Electrocautery

6.Equipments:sec.6-4of5-Electricity in the O.R

6.Equipments:sec.6-3of5-BIS & PSI

6.Equipments:sec.6-2of5-EEG

6.Equipments:sec.6-1of5-Cerebral Oximetry

7.Equipments:sec.5-13of13-Pacemaker part 2

6.Equipments:sec.5-12of13-Pacemakers:Part1

6.Equipments:sec.5-11of13-Torsades de pointes

6.Equipments:sec.5-10of13-Wolff-Parkinson-White syndrome

6.Equipments:sec.5-9of13-Reentry pathways

6.Equipments:sec.5-8of13-Antidysrhythmic Medications

6.Equipments:sec.5-7of13-Heart Block

6.Equipmemts:sec.5-6of13-Selected rhythm disturbances

6.Equipments:sec.5-5of13-Axis Deviation

6.Equipments:sec.5-4of13-Vectors

6.Equipments:sec.5-3of13-EKG:Normal Values and Abnormalities

6.Equipments:sec.5-2of13-EKG and cardiac action potential

6.Equipments:sec.5-1of13-Cardiac Conduction system

6.Equipments:sec.4-12of12-Esophageal Doppler

6.Equipments:sec.4-11of12-Pulse Contour Analysis

6.Equipments:sec.4-10of12-Mixed venous oxygen saturation

6.Equipments:sec.4-9of12-Cardiac Output

6.Equipments:sec.4-8of12-PA catheter:Abnormal

6.Equipments:sec.4-7of12-PA cath tip placement

6.Equipments:sec.4-6of12-PA waveform

6.Equipments:sec.4-5of12-CVP:Abnormal waveform

6.Equipments:sec.4:4of12-CVP interpretation

6.Equipments:sec.4-3of12-CVP-normal waveform

6.Equipments:sec.4-2of12-CVP:placement

6.Equipments:sec.4-1of12-BP measurement

6.Equipments:sec.3-9of9-Measurement of Exhaled Gases

6.Equipments:sec.3-8of9-pulse ox limitation

6.Equipments:sec.3-7of9-Pulse oximetry

6.Equipments:sec.3-6of9-Pulse ox relation to oxyhgb curve

6.Equipments:sec.3-5of9-Pulse Oximeter

6.Equipments:sec.3-4of9-Causes of high & low ETCO2

6.Equipments:sec.3-3of9-Capnograph abnormal waveform

6.Equipments:sec.3-2of9-Capnography Waveform

6.Equipments:sec.3-1of9-Assessment of pulmonary resistance a

6.Equipmemts:sec.2-4of4-Bain system

6.Equipments:sec2-3of4-Mapleson Circuit

6.Equipments:sec2:2of4-Circle System

6.Equipments:sec.2-1of4-Classification of breathing circuits

6.Equipments:sec.1-26of26-OSHA RECOMMENDATION regarding inha

6.Equipments:sec.1-25of26-Scavenger system

6.Equipments:sec.1-24of26-High pressure alarm

6.Equipments:sec.1-23of26-Low pressure alarm

6.Equipments:sec.1-22of26-Amsorb plus

6.Equipments:sec.1-21of26-Soda Lime

6.Equipments:sec.1-20of26-Mechanical Ventilation

6.Equipments:sec.1-19of26-VCV vs PCV

6.Equipments:sec.1-18of26-Piston Ventilator

6.Equipments:sec.1-17of26-Pneumatic Bellows

6.Equipments:sec.1-16of26-Oxygen flush valve & ventilatory s

6.Equipmets:sec.1-15of27-Oxygen pipeline supply failure

6.Equipments:sec.1-14of26-Oxygen analyzer

6.Equipments:sec.1-13of26-Tec 6 Desflurane Vaporizer

6.Equipments:sec.1-12of26-Variable Bypass Vaporizer:Overview

6.Equipments:sec.1-11of26-Circuit Compliance

6.Equipments:sec.1-10of26-Fresh Gas Coupling

9.Equipments:sec.1-9of26-Flowmeter FiO2 calculation

6.Equipments:sec.1-8of26-Flowmeters & Reynolds Number

6.Equipments:sec.1-7of26-Hypoxia prevention safety device

6.Equipments:sec.1-6of26-Failsafe device

6.Equipments:sec.1-5of26-Safe Handling of Gas Cylinders

6.Equipments:sec.1-4of26-Gas Cylinder

6.Equipments:sec.1-3of26-DISS & PISS

6.Equipments:sec.1-2of26-The SPDD Model

6.Equipment:sec.1-1of26-The anesthesia Machine

5.Pharmacology2:sec.4:11of11-Antagonist

5.Pharmacology2:sec.4-10of11-Partial agonist

5.Pharmacology2:sec.4-9of11-skeletal muscle rigidity

5.Pharmacology2:sec.4-8of11-Methadone

5.Pharmacology2:sec4-7of11-Remifentanil

5.Pharmacology2:sec.4-6of11-Alfentanil

5.Pharmacology2:sec.4-5of11-Meperidine

5.Pharmacology2:sec.4-4of11-Metabolism

5.Pharmacologu2:sec.2-3of11-Relative potency and dependence

5.Pharmacology2:sec.4-2of11-systemic effects

5.Pharmacology2:sec.4-1of11-MOA pain

5.Pharmacology2:sec.2-5of5-Sugammadex

5.Pharmacology2:sec.2-4of5-Muscarinic Antagonists:side effec

5.Pharmacology2:sec3-3of5-Cholinergic side effects

5.Pharmacology2:sec.3-2of5-Pharmacokinetic Neostigmine

5.Pharmacology2:sec.3-1of5-AchE inhibitors:MOA

5.Pharmacology2:sec.2-17of17-Anaphylaxis & NMB

5.Pharmacology2:sec.2-16of17-CV effects of NMB

5.Pharmacology2:sec.2:15of17-Factors that potentiate NM bloc

5.Pharmacology2:sec.2-14of17-Metabolism of Nondepolarizers

5.Pharmacology2:sec.2-13of17-Potency

5.Pharmacology2:sec.2-12of17-Diseases with altered responses

5.Pharmacology2:sec.2-11of17-Post-op myalgia with sux

5.Pharmacology2:sec.2-10of17-Sux Black Box warning

5.Pharmacology2:sec.2-9of17-Dibucaine Test

5.Pharmacology2:sec.2-8of17-Factors that reduce pseudocholin

5.Pharmacology2:sec.2-7of17-Synonym for pseudocholinesterase

5.Pharmacology2:sec.2-6of17-Succinylcholine side effects

5.Pharmacology2:sec.-5of17-Testing recovery from NM blockade

5.Pharmacology2:sec.2-4of17-Phase1 vs Phase 2 block

5.Pharmacology2:sec.2-3of17-Mechanism of fade

5.Pharmacology2:sec.2-2of17-Extrajunctional Receptors

5.Pharmacology2:sec.2-1of17-Neuromuscular Junction Physiolog

5.Pharmacology2:sec.1-15of15-Additives

5.Pharmacology2:sec.1-14of15-Emla Cream

5.Pharmacology2:sec.1-13of15-Methemoglobinemia

5.Pharmacology2:sec.1-12of15-Tumescent Anesthesia

5.Pharmacology2:sec.1-11of15- Treatment for LAST

5.Pharmacology2:sec.1-10-15-LAST

5.Pharmacology2:sec.1-9of10-Maximum allowable dose

5.Pharmacology2:sec.1-8of15-uptake & termination of action

5.Pharmacology2:sec.1-7of15-Acid base chemistry

5.Pharmacology2:sec.1-6of15-onset, potency, Duration of Acti

5.Pharmacology2:sec.1-5of15-Esters & Amides

5.Pharmacology2:sec1-4of15-MOA

5.Pharmacology2:sec.3of15-The action potential & effect ofLA

5.Pharmacology2:sec.1-2of15-voltage gated sodium channel

5.Pharmacology2.:sec.1-1of15-Peripheral Nerves

4.Pharmacology1:sec.5-11of11-Evoked Potential Monitoring

4.Pharmacology1:sec.5-10of11-Neurophysiologic effects

4.Pharmacology1:sec.4-9of11-Pulmonary effects:PaO2

4.Pharmacology1:sec.5-8of11-Pulmonary effects:PaCO2

4.Pharmacology1:sec.4-7of11-Cardiovascular effects

4.Pharmacology1:sec5:6of11-site of anesthetic action

4.Pharmacology1:sec.5-5of11-MOA:New way of Thinking

4.Pharmacology1:sec.5-4of11-MOA-old way of thinking

4.Pharmacology1:sec.5-3of11-MAc:Factors that affect Potency

4.Pharmacology1:sec.5-2of11-MAC

4.Pharmacology1:sec.5-1of11-Nitrous Oxide:Peculiarities

4.Pharmacology1:sec.4-10of10-Cardiac Shunti and FA/Fi

4.Pharmacology:sec.4-9of-10-second Gas effect

4.Pharmacology1:sec.4-8of10-Concentration Effect

4.Pharmacology1:sec.4-7of10-Hepatic Metabolism of Inhalation

4.Pharmacology1:sec.4-6of-10-Distribution

4.Pharmacology1:sec.4-5of10: factors affecting FA/FI

4.Pharmacology1:sec.4-4of10:FA/FI curves

4.Pharmacology1:sec.4-3of10-Solubility and the blood:Gas coe

4.Pharmacology1:sec.4-2of10-Physical properties

4.Pharmacology1:sec.4-1of10-Chemical Structures

4.Pharmacology:sec.3-10of10-Flumazenil

4.Pharmacology1-sec.3-9of10-Benzodiazepine

4.Pharmacology1:sec.3-8of10-Dexmedetomidine

4.Pharmacology1:sec.3-7of10-Barbiturates

4.Pharmacology1:sec.6-10-Etomidate Part2

4.Pharmacology1:sec.3-5of10-Etomidate

4.Pharmacology1:sec.3-4of10-Ketamine

4.Pharmacology1:sec.3-3of10-Fospropofol

4.Pharmacology1:sec.3-2of10-Propofol Part2

4.Pharmacology1:sec.3-1of10-Propofol

4.Pharmacology1:sec2-5of5-Stereochemistry,Enantiomers

4.Pharmacology1:sec.2-4of5-ED50,LD50,Therapeutic index

4.Pharmacology1:sec.2-3of5-Agonist, Antagonist

4.Pharmacology1:sec.2-2of5-Dose Response Curve

4.Pharmacology1:sec.2-1of5-Overview Pharmacodynamics

4.Pharmacology1-sec.1-13of13-Metabolism in the Plasma

4.Pharmacology1-sec.1-12of13-Renal Elimination

4.Pharmacology1-sec.1-11of13-P450 enzymes

4.Pharmacology1-sec.1-10of13-Hepatic Clearance

4.Pharmacology1:sec.1-9of13-phase 1,2,3 reactions

4.Pharmacology-sec.1-8of13-Zero vs. First Order Kinetics

4.Pharmacology:sec.1-7of13-Plasma Protein Binding

4.Pharmacology:sec.1-6of13-Ion Trapping

4.Pharcmacology-sec.1-5of13-pKa,pH and Ionization

4.Pharmacology:sec.1-4of13-Elimination Half-time and context

4. Pharmacology 1:sec1-3of13-Multi-compartment Models

4.Pharm1-sec.1-2of13-Clearance & Steady state

4.Pharm1-sec.1-1of13-Volume of Distribution

3.Cardiac:sec.3-23of23-Subclavian Steal Syndrome

3.Cardiac:sec.3-22of23-Carotid Endarterectomy and stenting

3.Cardiac:sec.3-21of23-Anterior Spinal Artery Syndrome

3.Cardiac:sec.3-20of23-Aortic Cross Clamp

3.Cardiac:sec.319of23-AAA

3.Cardiac:sec.1-18of23-Aortic Aneurysm:Classification

3.Cardiac.sec.3-17of23-Mechanical Cardiac Support

3.Cardiac:Sec.3-16of23-CPB:key facts

3.Cardiac:sec.3-15of23-Cardiopulmonary Bypass

3.Cardiac:sec.3-14of23-PCI (Stents)

3.Cardiac:sec.3-13of23-Obstructive Hypertrophic Cardiomyopat

3.Cardiac:sec.3-12of23-Infective Endocarditis

3.Cardiac:sec.3-11of23-Cardiac Tamponade:Anesthetic mgmt

3.Cardiac:sec.3-10of23-Cardiac Tamponade

3.Cardiac:sec.3-9of23-Pericarditis

3.Cardiac:sec.3-8of123-CCB

3.Cardiac:sec.3-7of23-Antihypertensive Agents

3.Cardiac:sec.3-6of23-HTN:secondary

3.Cardiac:sec.3-5of23-Hypertension

3.Cardiac:sec.3-4of23-Heart Failure:Systolic bs Diastolic

3.Cardiac:sec.3-3of23-Diastolic Compliance

3.Cardiac:Sec.3-2of23-Myocardial O2 Imbalance

3.Cardiac:Sec.3-1of23-Assessment of Perioperative CV Risk

3.Cardiac-sec.2-7of7-Pathologic Murmur

3.Cardiac:sec.2-6of7-Aortic Regurgitation

3. Cardiac:sec.2-5of7-Mitral Regurgitation

3.Cardiac:Sec.2-4of7-Mitral Stenosis

3.Cardiac:sec.1-3of7-Aortic Stenosis

3.Cardiac:Sec.2-2of7-Concentric & Eccentric Hypertrophy

3.Cardiac:Sec.2-1of7-Heart Sounds

3. Cardiac Sec.1-17of17-Regulation of Vascular Smooth Muscle

3.Cardiac:sec.1-16of17-Myocardial O2 supply & demand

3. Cardiac Sec.1-15of17-Coronary Perfusion Left vs Right

3. Cardiac:sec.1-14of17-Coronary Perfusion

3.Cardiac-sec.1:13of17-Coronary Circultaion

3.Cardiac.sec.1-12of17-Pressure volume loop step by step

3. Cardiac Sec.1-11of17-Pressure Volume Loop

3.Cardiac Sec.10of17-Wiggers Diagram

3. Cardiac:sec.1-9of17: Afterload

3.Cardiac: sec.1-8of17-Contractility and Excitation Coupling

3.Cardiac-sec.1-7of17-Preload and Frank-starling Mechanism

3.Cardiac Sec.1-6of17-Hemodynamic Calculations

3. Cardiac Sec.1-5of17-Ohm’s Law

3.Cardiac Sec.1-4of17-Oxygen Delivery

3. Cardiac Sec.1-3of17-Cardiac Action Potential:SA Node

3.Cardiac Sec. 1-2of17-Cardiac Action Potential

3.Cardiac Sec. 1 Bonus Resting potential

3.Cardiac Sec.1-1of17-The Myocyte

2.ANS: 24of24-Alpha Antagonist

2.ANS:23of24-Beta Antagonist

2. ANS: 22of 24-Adrenergic Agonist and vasopressin

2.ANS:21of24-Heart Transplant,Glomangioma, multiple system

2.ANS:20of24- Occulocardiac,Cushinf,Celiac, Chemoreceptor

2. ANS:19of24-Bezold-Jarisch and Bainbridge Reflexes

2. ANS 18of24- Baroreceptor Reflex: Effects of Drugs

2. ANS:17of24- Baroreceptor Reflex

2. ANS-16of24- Transcellular potassium shift

2.ANS-15of24-Adrenal Medulla

2.ANS-14of24-Sympathetic Ganglia

2. ANS-13of24- Bird’s eye view of the SNS and PNS

2.ANS 12of24-Autonomic Reflex Arc

2.ANS-11of24-ACH synthesis, release & metabolism

2. ANS-10of24-Catecholamine Metabolism

2.ANS-9of24-Norepinephrine Termination of Action

2. ANS-8of24-Norepinephrine Synthesis & Release

2.ANS-7of24 PDE3

2. ANS-6of24-Alpha-2 Receptor

2. ANS-5of24 ANS Receptors & Phy: Part 2

2. ANS-4of24- Ans receptor ans physiologic Action

2. AND 3of24- signal transduction: from Receptor to 2nd mess

2. ANS-2of24-GPCR

2. ANS-1of24-cellular communication

1. Respiratory Bonus 3

1. Respiratory Bonus 2

1.Respiratory BONUS

1. Respiratory Sec.2-24of24 HPV

1. Respiratory Sec.2 23of24- Pulmonary Reflexes

1. Respiratory Sec.2-22of24 Peripheral Chemoreceptors

1. Respiratory Sec.2-21of24 Control of Ventilation:Central C

1. Respiratory Sec.2 20of24-Control of Ventilation:Neural Co

1. Respiratory Sec.2-19of24-CO2 ventilatory Response Curve

1. Respiratory Sec.2-18of24- Hypercapnia

1. Respiratory Sec.2 17of24-Haldane Effect

1. Respiratory Sec.2 16of24-CO2 transport

1. Respiratory Sec.2-15of24- Cellular Energetics

1. Respiratory Sec.2-14of24-Oxyhemoglobin Dissociation Curve

1. Respiratory Sec.2 13of24-CaO2

1. Respiratory Sec.2-12of24- Closing volume and Capacity

1. Respiratory Sec.2-11of24-FRC

1. Respiratory Sec.2 10of24-Lung Volumes & Capacities

1. Respiratory Sec.2-9of24-A-a Grdadient

1. Respiratory Sec.2 8of24-Alveolar Gas Equation

1. Respiratory Sec.2- 7of24 West Zones

1. Respiratory sec.2-6of24- Alveolar Surface Tension

1. Respiratory Sec.2-5of24-V/Q Mismatch

1. Respiratory Sec.2-4of24-Alveolar Compliance Curve

1. Respiratory Sec.2-3of24-Dead Space and Vd/Vt

1.Respiratory sec.2-2of24- Ventilation

1. Respiratory Sec.2-1of21-Moving air in & out of lungs

1.Respiratory Sec1-7of7 Lower Airway

1. Respiratory Sec.1-6of7-Upper Airway Anatomy

1.Respiratory Sec.1-5of7-Laryngospasm & Larson’s

1. Respiratory Sec.1-4of7-Laryngeal Anatomy

1.Respiratory Sec.1-3of7 Infiltration Block larynx

1. Respiratory Sec.1-2of7 Innervation of upper airway

1. Respiratory Sec.1-1of7 Laryngeal Muscle

1. Respiratory Sec.4-21of21 Airway Exchange Catheter

1. Respiratory Sec.4-20of21 Extubation

1.Respiratory Sec.4 19of21 Invasive Airways

1. Respiratory Sec.4-18of21 Retrograde Intubation

1. Respiratory Sec.4-17of21 Bronchial Blocker

1.Respiratory sec.4-16of21 Lighted Stylet

1. Respiratory Sec.4-15of21 Eschmann introducer

1. Respiratory Sec.4-14of21 Bullard Laryngoscope

1. Respiratory Sec.4-13of21 Flexible Fiberoptic Bronchoscope

1.Respiratory Sec.4-12of21 -Combitube

1.Respiratory Sec.4-11of21 LMA:Special Consideration

1. Respiratory Sec.4-10of21 LMA:Variations

1. Respiratory Sec.4 9of21-LMA:Design

1.Respiratory Sec.4-8of21 ETT design and sizing

1. Respiratory sec4- 7of21 OPA and NPA

1. Respiratory Sec.4-6of21 Positioning for Airway mgmt

1. Respiratory sec.4 5of21 Syndromes Assoc. with difficult

1. Respiratory sec.4 4of21 Five Questions to ans. B4 airway

1.Respiratory sec.4 3of21 Laryngeal Assessment Technique

1. Respiratory Sec. 4 2of21 Airway Assessment P2

1.Respiratory Sec.4 1of21 Airway Assessment Techniques: 1

1. Respiratory Sec.3 21of21-Mediastinoscopy

1. Respiratory Sec.3 20of21 One Lung Ventilation: Part2

1.Respiratory Sec.3 19of21 One-Lung Ventilation: Part1

1. Respiratory Sec.3-18of21- Indications of Mechanical Vent

1. Respiratory Sec.3- 17of21 Carboxyhemoglobin

1. Respiratory Sec.3- 16of21 Pulmonary HTN

1. Respiratory Sec.3-15of21 Venous Air Embolism

1. Respiratory Sec.3- 14of21 Pneumothorax and Flail Chest

1.Respiratory Sec.3-13of31 Aspiration Pneumonitis & VAP

1.Respi 12of 31 Cystic Fibrosis

1. Respiratory Sec3-12of21 Restrictive Lung Disease

1.Respi sec.2- 11of21 Dynamic Hyperinflation (Auto-PEEP)

1.Respiratory-Sec.3- 10of21 COPD:Anesthetic Mgmt

1.Respi-sec3-9of21 COPD

1. Respi-sec3- 8of21 Intraoperative Bronchospasm

1.Respiratory Sec.3- 7of21 Asthma

1.Respiratory-sec3- 6of21 Obstructive vs Restrictive

1.Respiratory Sec.3 5of21- Post-op pulmonary complications

1.Respiratory Sec.3 4of21- Flow-Volume Loops

1.Respiratory-Sec.3-3of21-PFT

1. Respiratory Sec.3 2of21Pulmonary Pharmacology

1. Respiratory-Sec3- 1of21 Control of Airway Diameter

Test